Company Profile

Lombard Medical, is a medical technology company specializing in developing, manufacturing, and marketing endovascular stent-grafts that address significant unmet needs in the repair of aortic aneurysms. The Company is focused on device solutions for the $1.4 billion per annum abdominal aortic aneurysm repair market and its lead product, Aorfix™, is an endovascular stent graft which has been specifically designed to solve the problems that exist in treating complex tortuous anatomy, which is often present in advanced AAA disease. Aorfix is the only endovascular stent graft approved by the United States Food and Drug Administration (FDA) and the Japanese Ministry of Health, Labor and Welfare for the treatment of AAAs with angulation at the neck of the aneurysm of up to 90 degrees.